Primary cutaneous amyloidosis: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
[[Category:Amyloidosis]] | [[Category:Amyloidosis]] | ||
{{stub}} | {{stub}} | ||
<gallery caption="Primary_cutaneous_amyloidosis"> | |||
File:Macular_amyloidosis.jpg|Macular amyloidosis | |||
File:Histopathology_of_lichen_amyloidosis_with_Congo_red.jpg|Histopathology of lichen amyloidosis with Congo red | |||
File:Lichen_amyloidosis_on_leg_1.jpg|Lichen amyloidosis on leg | |||
File:Lichen_amyloidosis_on_leg_2.jpg|Lichen amyloidosis on leg | |||
</gallery> | |||
Revision as of 05:06, 18 February 2025
Primary cutaneous amyloidosis is a form of amyloidosis, a group of diseases in which an abnormal protein, known as amyloid, builds up in tissues and organs. In primary cutaneous amyloidosis, the skin is the organ that is primarily affected.
Symptoms
The symptoms of primary cutaneous amyloidosis can vary, but often include itching, changes in skin color, and the development of raised skin lesions. These symptoms are typically chronic and can significantly impact a person's quality of life.
Causes
The exact cause of primary cutaneous amyloidosis is unknown. However, it is believed to be related to an abnormal response of the skin to injury or inflammation. Some studies have suggested a genetic component, as the condition often runs in families.
Diagnosis
Diagnosis of primary cutaneous amyloidosis is typically made through a combination of clinical examination and skin biopsy. The biopsy can reveal the presence of amyloid in the skin.
Treatment
Treatment for primary cutaneous amyloidosis is aimed at relieving symptoms and preventing further accumulation of amyloid in the skin. This can include the use of topical creams, oral medications, and in some cases, light therapy.
See also
References
<references />


